AI-driven health-tech company Eolas Medical has secured $12m (€10.15m) in Series A funding to expand its platform across UK National Health Service (NHS) sites and support international growth.

The clinician-founded start-up focuses on providing healthcare professionals with fast, reliable access to evidence-based information at the point of care.

The platform, already used at more than 400 clinical sites across the UK, is designed to deliver “point-of-care knowledge tools supporting clinical safety, adherence and productivity” through a single, searchable source of truth, reportedly up to ten times faster than traditional methods.

Dr Declan Kelly, founder and CEO of Eolas Medical, said: “Eolas has always been about solving a very practical problem: giving healthcare professionals fast, reliable access to the knowledge they need, when they need it. This is especially important in acute settings, where staff are under pressure to make decisions quickly and safely – particularly in the winter.”

The company aims to enhance clinical safety by eliminating the inefficiencies of fragmented or outdated information sources. Kelly added: “As AI develops, the next phase is about making that access even more usable, so staff can ask a question and get a clear, evidence-backed answer straight away, in plain language.”

Acton Capital led the funding round, with managing partner Fritz Oidtmann noting: “Our conversations with clinicians showed remarkable enthusiasm for Eolas. Clinicians love the product. The benefit is immediate, the value is clear, and this conviction and their unique positioning in the market strongly shaped our excitement to partner with Eolas Medical.”

Founded by doctors, Eolas Medical’s AI platform captures, organises, and mobilises medical knowledge, ensuring seamless access for healthcare professionals.

View the full article to see how Eolas Medical is transforming healthcare safety and decision-making with AI.